title: Long-term treatment for lifetime disorders?
authors.affiliation: Schizophrenia Program, University of Michigan Medical Center, Ann Arbor 48109-0704.
authors.forename: J F
authors.initials: JF
authors.lastname: Greden
authors.forename: R
authors.initials: R
authors.lastname: Tandon
mesh_terms: D000208:Acute Disease; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D015201:Meta-Analysis as Topic; D019964:Mood Disorders / Q000188:drug therapy / Q000517:prevention & control; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000517:prevention & control
chemical_list: D014150:Antipsychotic Agents